Petros Pharmaceuticals Q2 EPS $(0.22), Sales $2.46M
Petros Pharmaceuticals (NASDAQ:PTPI) reported quarterly losses of $(0.22) per share. The company reported $2.46 million in sales this quarter.
Petros Pharmaceuticals Seeks to Disrupt the Prescription Erectile Dysfunction (ED) Market
Fady Boctor, President and Chief Commercial Officer of Petros Pharmaceuticals
26 Stocks Moving in Wednesday’s Pre-Market Session
Gainers
Acasti Pharma Inc. (NASDAQ: ACST) rose 39% to $0.75 in pre-market trading after jumping 10% on Tuesday. The company reported a narrower FY21 loss.
34 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
County Bancorp, Inc. (NASDAQ: ICBK) shares surged 45.5% to $34.03. Nicolet Bankshares reported a deal to buy County Bancorp.
21 Stocks Moving in Tuesday’s Pre-Market Session
Gainers
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) rose 29.2% to $3.71 in pre-market trading as traders circulated an article titled "Revisiting Adial Pharmaceuticals: EMA Approval For Alcohol Use Disorder Pill Is A Critical Catalyst."
50 Biggest Movers From Yesterday
Gainers
Verve Therapeutics, Inc. (NASDAQ: VERV) shares surged 68% to settle at $31.92 on Thursday after the company priced its IPO at $19 per share.
54 Biggest Movers From Yesterday
Gainers
Flanigan's Enterprises, Inc. (NYSE: BDL) shares surged 40.6% to close at $34.90 on Tuesday after the company reported results for the 13 weeks and the 26 weeks ended April 3, 2021.